| Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study LF Van Gaal, AM Rissanen, AJ Scheen, O Ziegler, S Rössner The Lancet 365 (9468), 1389-1397, 2005 | 2048 | 2005 |
| The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis D Cota, G Marsicano, M Tschöp, Y Grübler, C Flachskamm, M Schubert, ... The Journal of clinical investigation 112 (3), 423-431, 2003 | 1488 | 2003 |
| Pharmacological management of obesity: an endocrine Society clinical practice guideline CM Apovian, LJ Aronne, DH Bessesen, ME McDonnell, MH Murad, ... The Journal of Clinical Endocrinology & Metabolism 100 (2), 342-362, 2015 | 1453 | 2015 |
| Obesity and the polycystic ovary syndrome A Gambineri, C Pelusi, V Vicennati, U Pagotto, R Pasquali International journal of obesity 26 (7), 883-896, 2002 | 1206 | 2002 |
| The emerging role of the endocannabinoid system in endocrine regulation and energy balance U Pagotto, G Marsicano, D Cota, B Lutz, R Pasquali Endocrine reviews 27 (1), 73-100, 2006 | 1160 | 2006 |
| Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia I Matias, MP Gonthier, P Orlando, V Martiadis, L De Petrocellis, C Cervino, ... The Journal of Clinical Endocrinology & Metabolism 91 (8), 3171-3180, 2006 | 767 | 2006 |
| Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity E Bugianesi, U Pagotto, R Manini, E Vanni, A Gastaldelli, R de Iasio, ... The journal of clinical endocrinology & metabolism 90 (6), 3498-3504, 2005 | 553 | 2005 |
| The impact of obesity on reproduction in women with polycystic ovary syndrome R Pasquali, A Gambineri, U Pagotto BJOG: An International Journal of Obstetrics & Gynaecology 113 (10), 1148-1159, 2006 | 537 | 2006 |
| Endogenous cannabinoid system as a modulator of food intake D Cota, G Marsicano, B Lutz, V Vicennati, GK Stalla, R Pasquali, ... International journal of obesity 27 (3), 289-301, 2003 | 449 | 2003 |
| The hypothalamic‐pituitary‐adrenal axis activity in obesity and the metabolic syndrome R Pasquali, V Vicennati, M Cacciari, U Pagotto Annals of the New York Academy of Sciences 1083 (1), 111-128, 2006 | 430 | 2006 |
| Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's … G Di Dalmazi, V Vicennati, S Garelli, E Casadio, E Rinaldi, E Giampalma, ... The lancet Diabetes & endocrinology 2 (5), 396-405, 2014 | 413 | 2014 |
| Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study A Gambineri, L Patton, P Altieri, U Pagotto, C Pizzi, L Manzoli, R Pasquali Diabetes 61 (9), 2369-2374, 2012 | 286 | 2012 |
| Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome A Gambineri, C Pelusi, S Genghini, AM Morselli‐Labate, M Cacciari, ... Clinical endocrinology 60 (2), 241-249, 2004 | 285 | 2004 |
| Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels U Pagotto, A Gambineri, V Vicennati, ML Heiman, M Tschöp, R Pasquali The Journal of Clinical Endocrinology & Metabolism 87 (12), 5625-5629, 2002 | 278 | 2002 |
| Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo … A Gambineri, L Patton, A Vaccina, M Cacciari, AM Morselli-Labate, ... The Journal of Clinical Endocrinology & Metabolism 91 (10), 3970-3980, 2006 | 277 | 2006 |
| Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression M Theodoropoulou, J Zhang, S Laupheimer, M Paez-Pereda, C Erneux, ... Cancer research 66 (3), 1576-1582, 2006 | 269 | 2006 |
| Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function D Cota, MA Steiner, G Marsicano, C Cervino, JP Herman, Y Grubler, ... Endocrinology 148 (4), 1574-1581, 2007 | 248 | 2007 |
| Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors A Gambineri, C Pelusi, E Manicardi, V Vicennati, M Cacciari, ... Diabetes 53 (9), 2353-2358, 2004 | 241 | 2004 |
| CB1 signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance C Quarta, L Bellocchio, G Mancini, R Mazza, C Cervino, LJ Braulke, ... Cell metabolism 11 (4), 273-285, 2010 | 231 | 2010 |
| Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross … G Di Dalmazi, V Vicennati, E Rinaldi, AM Morselli-Labate, E Giampalma, ... European Journal of Endocrinology 166 (4), 669-677, 2012 | 225 | 2012 |
